537 related articles for article (PubMed ID: 30206805)
1. Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome.
Mu L; Li R; Lai Y; Zhao Y; Qiao J
J Endocrinol Invest; 2019 May; 42(5):541-548. PubMed ID: 30206805
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
3. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
4. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
[TBL] [Abstract][Full Text] [Related]
6. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome.
Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S
Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143
[TBL] [Abstract][Full Text] [Related]
7. Independent predictors of cardiovascular risk in polycystic ovarian syndrome.
Türkçüoğlu I; Kafkasli A; Meydanli MM; Ozyalin F; Taşkapan C
Gynecol Endocrinol; 2011 Nov; 27(11):915-9. PubMed ID: 21294689
[TBL] [Abstract][Full Text] [Related]
8. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome.
Kuppusamy S; Pal GK; Habeebullah S; Ananthanarayanan PH; Pal P
Endocr Res; 2015; 40(1):37-43. PubMed ID: 24866562
[TBL] [Abstract][Full Text] [Related]
9. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome.
Bicer M; Alan M; Alarslan P; Guler A; Kocabas GU; Imamoglu C; Aksit M; Bozkaya G; Isil AM; Baloglu A; Aslanipoiur B; Calan M
J Endocrinol Invest; 2019 Mar; 42(3):303-312. PubMed ID: 29956214
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
14. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
16. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.
Aziz M; Sidelmann JJ; Faber J; Wissing ML; Naver KV; Mikkelsen AL; Nilas L; Skouby SO
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1082-9. PubMed ID: 26123797
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients.
Oztas E; Ozler S; Tokmak A; Yilmaz N; Celik HT; Kazancı FH; Danisman N; Ergin M; Yakut HI
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():89-93. PubMed ID: 26802256
[TBL] [Abstract][Full Text] [Related]
19. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
[TBL] [Abstract][Full Text] [Related]
20. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
